CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.
about
Pharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme InhibitorsSacubitril Is Selectively Activated by Carboxylesterase 1 (CES1) in the Liver and the Activation Is Affected by CES1 Genetic Variation.Regulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus.CES1P1 variant -816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril.Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory StudyPopulation Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants.Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender.Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic Polymorphisms.Institutional profile of pharmacogenetics within University of Michigan College of Pharmacy.Reappraisal of the genetic diversity and pharmacogenetic assessment of CES1.The Pharmacokinetics of Enalapril in Relation to CES1 Genotype in Healthy Danish Volunteers.The impact of CES1 genotypes on the pharmacokinetics of methylphenidate in healthy Danish subjects.A Comprehensive Functional Assessment of Carboxylesterase 1 Nonsynonymous Polymorphisms.Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related Toxicity.Clinical implications of genetic variation in carboxylesterase drug metabolism.Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate
P2860
Q28554328-D241649F-1D87-4488-AEFD-E9351BA3FA7EQ36736998-FB8E7F7E-0F96-4E49-B3DC-0C18A04CBFDEQ36767978-D09BA760-6B54-4C3B-97A9-A57909C5D124Q36896568-5D756A7F-C1DB-40D2-B8FB-D75E51ACB88DQ37137803-5FEE7DA2-7B79-4A18-B70A-301EB69288E2Q37700662-BF5E18F0-7D09-4B91-B3F4-4FCA5E14ED32Q39404447-94C25368-CCA2-4E3B-9542-016CA886AB0CQ40734518-ABF1E352-FBDE-4BBF-8659-3DEBC26E35CCQ47312891-458EA7E6-FA4C-42F9-AB78-70DEE683918CQ47652000-A1DB1CFC-1630-4D7A-83C4-F640C6DA8ABCQ47686935-455A4E7E-9710-4FEB-82B7-5D1C21D6792CQ47827847-1CDEA941-CB1A-485A-81E1-B831D8C89583Q47909214-23B3C38A-42DE-4CAB-BC3C-C0DC3869C347Q48061495-51E9F3E7-81CD-44D9-A5AF-EF6C92287867Q49628042-84648C4E-9D61-4A79-B693-983F8FFE0EADQ57112884-91D94203-CEC0-4D2B-A46F-098B32039A0E
P2860
CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CES1 genetic variation affects ...... -converting enzyme inhibitors.
@en
type
label
CES1 genetic variation affects ...... -converting enzyme inhibitors.
@en
prefLabel
CES1 genetic variation affects ...... -converting enzyme inhibitors.
@en
P2093
P2860
P356
P1476
CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors
@en
P2093
P2860
P2888
P304
P356
10.1038/TPJ.2015.42
P50
P577
2015-06-16T00:00:00Z
P6179
1052370246